SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 89.75 |
Enterprise Value ($M) | 47.47 |
Book Value ($M) | 55.07 |
Book Value / Share | 1.12 |
Price / Book | 1.63 |
NCAV ($M) | 40.21 |
NCAV / Share | 0.82 |
Price / NCAV | 2.23 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.19 |
Return on Assets (ROA) | -0.15 |
Return on Equity (ROE) | -0.16 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 16.66 |
Current Ratio | 16.66 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 43.27 |
Assets | 58.12 |
Liabilities | 3.05 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | 0.00 |
Net Income | 0.00 |
Earnings Per Share Basic And Diluted | n/a |
Earnings Per Share Diluted | n/a |
Earnings Per Share Basic | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 0.00 |
Cash from Investing | 0.00 |
Cash from Financing | 0.00 |
(click for more detail) |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 Form 10-K | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
18,908 | 92,482 | 20.45 | |
10,049 | 38,613 | 26.02 | |
8,295 | 69,734 | 11.90 | |
53,197 | 190,784 | 27.88 | |
(click for more detail) |
Similar Companies | |
---|---|
MDWD – MediWound Ltd. | MIRM – Mirum Pharmaceuticals, Inc. |
MNKD – MannKind Corporation | MRNS – Marinus Pharmaceuticals, Inc. |
MRUS – Merus N.V. |
Financial data and stock pages provided by
Fintel.io